GSK3B and major depressive disorder: Subjects with comorbid MDD/SUD had significantly lower levels of Gsk3β expression compared to control subjects (p < 0.003; Figure 4D; adjusted for significant effects of ZT time, duration of alcohol use disorder, and suicide).